These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 17984162

  • 1. An effect-size analysis of pharmacologic treatments for generalized anxiety disorder.
    Hidalgo RB, Tupler LA, Davidson JR.
    J Psychopharmacol; 2007 Nov; 21(8):864-72. PubMed ID: 17984162
    [Abstract] [Full Text] [Related]

  • 2. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A, Korotzer A, Gommoll C, Li D.
    Depress Anxiety; 2008 Nov; 25(10):854-61. PubMed ID: 18050245
    [Abstract] [Full Text] [Related]

  • 3. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH, Tiller J, Xie F, Trivedi MH.
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [Abstract] [Full Text] [Related]

  • 4. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study.
    Andreatini R, Sartori VA, Seabra ML, Leite JR.
    Phytother Res; 2002 Nov; 16(7):650-4. PubMed ID: 12410546
    [Abstract] [Full Text] [Related]

  • 5. Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder.
    Lydiard RB, Rickels K, Herman B, Feltner DE.
    Int J Neuropsychopharmacol; 2010 Mar; 13(2):229-41. PubMed ID: 19737439
    [Abstract] [Full Text] [Related]

  • 6. Generalized anxiety disorder versus panic disorder: participation in controlled efficacy trials.
    Mavissakalian MR, Zamar N.
    Compr Psychiatry; 2000 Mar; 41(4):253-8. PubMed ID: 10929792
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis and management of generalized anxiety disorder.
    Roerig JL.
    J Am Pharm Assoc (Wash); 1999 Mar; 39(6):811-21; quiz 877-9. PubMed ID: 10609447
    [Abstract] [Full Text] [Related]

  • 8. Early response and 8-week treatment outcome in GAD.
    Rynn M, Khalid-Khan S, Garcia-Espana JF, Etemad B, Rickels K.
    Depress Anxiety; 2006 Mar; 23(8):461-5. PubMed ID: 16845651
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial.
    Nicolini H, Bakish D, Duenas H, Spann M, Erickson J, Hallberg C, Ball S, Sagman D, Russell JM.
    Psychol Med; 2009 Feb; 39(2):267-76. PubMed ID: 18485261
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative efficacy and acceptability of pharmacotherapeutic agents for anxiety disorders in children and adolescents: a mixed treatment comparison meta-analysis.
    Uthman OA, Abdulmalik J.
    Curr Med Res Opin; 2010 Jan; 26(1):53-9. PubMed ID: 19905879
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
    Herrera-Arellano A, Jiménez-Ferrer E, Zamilpa A, Morales-Valdéz M, García-Valencia CE, Tortoriello J.
    Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.
    Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
    [Abstract] [Full Text] [Related]

  • 17. Anxiolytics, adrenergic agents, and naltrexone.
    Riddle MA, Bernstein GA, Cook EH, Leonard HL, March JS, Swanson JM.
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):546-56. PubMed ID: 10230186
    [Abstract] [Full Text] [Related]

  • 18. Use of anxiolytics in children.
    Siméon JG.
    Encephale; 1993 May; 19(2):71-4. PubMed ID: 7903927
    [Abstract] [Full Text] [Related]

  • 19. Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders.
    Witte S, Loew D, Gaus W.
    Phytother Res; 2005 Mar; 19(3):183-8. PubMed ID: 15934028
    [Abstract] [Full Text] [Related]

  • 20. Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications.
    Casacalenda N, Boulenger JP.
    Can J Psychiatry; 1998 Sep; 43(7):722-30. PubMed ID: 9773222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.